NASDAQ:PAHC Phibro Animal Health - PAHC Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Phibro Animal Health Co. Please log in to your account or sign up in order to add this asset to your watchlist. $14.54 +0.01 (+0.07%) (As of 03/24/2023 10:39 AM ET) Add Compare Share Share Today's Range$14.35▼$14.6350-Day Range$14.52▼$16.3752-Week Range$11.75▼$20.68Volume7,334 shsAverage Volume116,000 shsMarket Capitalization$588.87 millionP/E Ratio16.16Dividend Yield3.30%Price Target$18.00 ProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability Phibro Animal Health MarketRank™ ForecastAnalyst RatingHold2.00 Rating ScoreUpside/Downside23.8% Upside$18.00 Price TargetShort InterestHealthy2.44% of Float Sold ShortDividend StrengthModerateBased on Four FactorsSustainability-3.93Upright™ Environmental ScoreNews SentimentN/AInsider TradingN/AProj. Earnings Growth9.60%From $1.25 to $1.37 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.34 out of 5 starsMedical Sector240th out of 989 stocksPharmaceutical Preparations Industry100th out of 480 stocks 2.0 Analyst's Opinion Consensus RatingPhibro Animal Health has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, 1 hold rating, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of $18.00, Phibro Animal Health has a forecasted upside of 23.8% from its current price of $14.54.Amount of Analyst CoveragePhibro Animal Health has only been the subject of 1 research reports in the past 90 days. Previous Next 4.0 Short Interest Percentage of Shares Shorted2.44% of the float of Phibro Animal Health has been sold short.Short Interest Ratio / Days to CoverPhibro Animal Health has a short interest ratio ("days to cover") of 3.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Phibro Animal Health has recently decreased by 0.16%, indicating that investor sentiment is improving. Previous Next 2.5 Dividend Strength Dividend YieldPhibro Animal Health pays a meaningful dividend of 3.20%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthPhibro Animal Health does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Phibro Animal Health is 53.33%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Phibro Animal Health will have a dividend payout ratio of 35.04% next year. This indicates that Phibro Animal Health will be able to sustain or increase its dividend. Previous Next 1.1 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScorePhibro Animal Health has received a -45.84% net impact score from Upright. The largest negative impact of Phibro Animal Health in category "GHG emissions" seems to be driven mostly by its "Animal feed supplements", "Cattle vaccines", and "Poultry vaccines" products. See details.Environmental SustainabilityThe Environmental Impact score for Phibro Animal Health is -3.93. Previous Next N/A News and Social Media Coverage Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Phibro Animal Health insiders have not sold or bought any company stock.Percentage Held by Insiders50.06% of the stock of Phibro Animal Health is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions49.21% of the stock of Phibro Animal Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for Phibro Animal Health are expected to grow by 9.60% in the coming year, from $1.25 to $1.37 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Phibro Animal Health is 16.16, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 123.11.Price to Earnings Ratio vs. SectorThe P/E ratio of Phibro Animal Health is 16.16, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 96.90.Price to Earnings Growth RatioPhibro Animal Health has a PEG Ratio of 8.04. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioPhibro Animal Health has a P/B Ratio of 2.24. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Phibro Animal Health (NASDAQ:PAHC) StockPhibro Animal Health Corp. engages in the manufacture and supply of animal health and mineral nutrition products. It operates through the following segments: Animal Health, Mineral Nutrition, and Performance Products. The Animal Health segment develops and markets antibacterial, nutritional specialty products, and vaccines. The Mineral Nutrition segment consists of the formulations and concentrations of trace minerals such as zinc, manganese, copper, iron, and compounds. The Performance Products segment produces specialty ingredients for use in the personal care, automotive, industrial chemical, and chemical catalyst industries. The company was founded on May 11, 1946 and is headquartered in Teaneck, NJ.Read More Receive PAHC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Phibro Animal Health and its competitors with MarketBeat's FREE daily newsletter. Email Address PAHC Stock News HeadlinesFebruary 21, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Phibro Animal Health (PAHC) and Elanco Animal Health (ELAN)February 16, 2023 | finance.yahoo.comPhibro Animal Health Corporation to Participate in Barclays Global Healthcare ConferenceMarch 24, 2023 | Weiss Ratings (Ad)Urgent WarningThis was never meant for the general public. But it’s all there in black and white … A frightening plan that gives the Fed the power to track and even control your checking account, including ALL your financial transactions. A pilot test program is already underway. And it’s slated to launch at America’s largest banks as soon as May of this year! So, time to prepare is very short. Fortunately, there are a few key steps you can take to defend yourself …February 14, 2023 | finance.yahoo.comPhibro Animal Health Corporation to Participate in Bank of America 2023 Animal Health SummitFebruary 13, 2023 | finance.yahoo.comPhibro Animal Health (NASDAQ:PAHC) shareholders have endured a 51% loss from investing in the stock five years agoFebruary 11, 2023 | finance.yahoo.comPhibro Animal Health Corporation (NASDAQ:PAHC) Q2 2023 Earnings Call TranscriptFebruary 10, 2023 | msn.comStrong Demand Points To Better Second Half For Phibro Animal Health (PAHC)February 10, 2023 | msn.comPhibro Animal Health's Return On Capital Employed InsightsMarch 24, 2023 | Weiss Ratings (Ad)Urgent WarningThis was never meant for the general public. But it’s all there in black and white … A frightening plan that gives the Fed the power to track and even control your checking account, including ALL your financial transactions. A pilot test program is already underway. And it’s slated to launch at America’s largest banks as soon as May of this year! So, time to prepare is very short. Fortunately, there are a few key steps you can take to defend yourself …February 10, 2023 | msn.comPhibro (PAHC) Q2 Earnings Top Estimates, Gross Margin UpFebruary 9, 2023 | markets.businessinsider.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Abbott Labs (ABT) and Phibro Animal Health (PAHC)February 8, 2023 | finance.yahoo.comPhibro Animal Health (PAHC) Q2 Earnings and Revenues Beat EstimatesFebruary 6, 2023 | finance.yahoo.comPhibro Animal Health Corporation Announces the Appointment of Alejandro Bernal to Its Board of Directors and Declares Quarterly DividendFebruary 1, 2023 | finance.yahoo.comAnalysts Estimate Phibro Animal Health (PAHC) to Report a Decline in Earnings: What to Look Out forJanuary 26, 2023 | reuters.comPAHC.A - | Stock Price & Latest News | ReutersJanuary 24, 2023 | 247wallst.comPzena Investment Management Ups Stake in Phibro Animal HealthJanuary 20, 2023 | nasdaq.comPzena Investment Management Llc Ups Stake in Phibro Animal Health Corp (PAHC)January 17, 2023 | finance.yahoo.comImplied Volatility Surging for Phibro (PAHC) Stock OptionsJanuary 9, 2023 | finance.yahoo.comPhibro Animal Health Corporation to Host Webcast and Conference Call on December 2022 Quarterly Financial ResultsDecember 31, 2022 | thestreet.comPhibro Animal Health Corp. (PAHC) Stock Rises After IPODecember 13, 2022 | msn.comPhibro Animal Health's Return On Capital Employed OverviewNovember 16, 2022 | finance.yahoo.comPhibro (PAHC) Q1 Earnings Miss Estimates, Sales SurpassNovember 13, 2022 | seekingalpha.comPhibro Animal Health Corporation (PAHC) Q1 2023 Earnings Call TranscriptNovember 12, 2022 | finance.yahoo.comPhibro Animal Health (NASDAQ:PAHC) Has Announced A Dividend Of $0.12November 11, 2022 | finance.yahoo.comPhibro Animal Health First Quarter 2023 Earnings: EPS Misses ExpectationsNovember 9, 2022 | finance.yahoo.comPhibro Animal Health (PAHC) Misses Q1 Earnings EstimatesNovember 9, 2022 | finance.yahoo.comPhibro Animal Health Corporation Reports First Quarter Results, Revised GuidanceSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive PAHC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Phibro Animal Health and its competitors with MarketBeat's FREE daily newsletter. Email Address PAHC Company Calendar Last Earnings2/08/2023Ex-Dividend for 3/22 Dividend2/28/2023Dividend Payable3/22/2023Today3/24/2023Next Earnings (Estimated)5/03/2023Fiscal Year End6/30/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:PAHC CUSIPN/A CIK1069899 Webwww.pahc.com Phone(201) 329-7300Fax201-329-7399Employees1,860Year FoundedN/APrice Target and Rating Average Stock Price Forecast$18.00 High Stock Price Forecast$19.00 Low Stock Price Forecast$17.00 Forecasted Upside/Downside+23.9%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)$0.90 Trailing P/E Ratio16.14 Forward P/E Ratio11.62 P/E Growth7.96Net Income$49.17 million Net Margins3.73% Pretax Margin5.84% Return on Equity18.90% Return on Assets5.33% Debt Debt-to-Equity Ratio1.72 Current Ratio3.47 Quick Ratio1.75 Sales & Book Value Annual Sales$972.05 million Price / Sales0.61 Cash Flow$2.09 per share Price / Cash Flow6.96 Book Value$6.48 per share Price / Book2.24Miscellaneous Outstanding Shares40,504,000Free Float20,228,000Market Cap$588.52 million OptionableOptionable Beta0.60 Key ExecutivesJack C. BendheimChairman, President & Chief Executive OfficerLarry L. MillerChief Operating OfficerDamian FinioChief Financial OfficerThomas G. DaggerSecretary, Senior Vice President & General CounselMona DesaiVice President & ControllerKey CompetitorsAnaptysBioNASDAQ:ANABIntercept PharmaceuticalsNASDAQ:ICPTMineralys TherapeuticsNASDAQ:MLYSRAPT TherapeuticsNASDAQ:RAPTAmarinNASDAQ:AMRNView All CompetitorsInstitutional OwnershipRockefeller Capital Management L.P.Bought 2,484 shares on 3/6/2023Ownership: 0.006%Alliancebernstein L.P.Bought 3,518 shares on 2/16/2023Ownership: 0.071%State of WyomingBought 12,862 shares on 2/16/2023Ownership: 0.032%Legal & General Group PlcBought 756 shares on 2/15/2023Ownership: 0.124%Connors Investor Services Inc.Bought 3,100 shares on 2/15/2023Ownership: 0.032%View All Institutional Transactions PAHC Stock - Frequently Asked Questions Should I buy or sell Phibro Animal Health stock right now? 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Phibro Animal Health in the last year. There are currently 1 sell rating, 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" PAHC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PAHC, but not buy additional shares or sell existing shares. View PAHC analyst ratings or view top-rated stocks. What is Phibro Animal Health's stock price forecast for 2023? 3 brokers have issued twelve-month price targets for Phibro Animal Health's stock. Their PAHC share price forecasts range from $17.00 to $19.00. On average, they expect the company's share price to reach $18.00 in the next year. This suggests a possible upside of 23.9% from the stock's current price. View analysts price targets for PAHC or view top-rated stocks among Wall Street analysts. How have PAHC shares performed in 2023? Phibro Animal Health's stock was trading at $13.41 at the start of the year. Since then, PAHC shares have increased by 8.4% and is now trading at $14.53. View the best growth stocks for 2023 here. When is Phibro Animal Health's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 3rd 2023. View our PAHC earnings forecast. How were Phibro Animal Health's earnings last quarter? Phibro Animal Health Co. (NASDAQ:PAHC) announced its quarterly earnings results on Wednesday, February, 8th. The company reported $0.34 EPS for the quarter, beating analysts' consensus estimates of $0.30 by $0.04. The business earned $244.60 million during the quarter, compared to the consensus estimate of $238.44 million. Phibro Animal Health had a trailing twelve-month return on equity of 18.90% and a net margin of 3.73%. How often does Phibro Animal Health pay dividends? What is the dividend yield for Phibro Animal Health? Phibro Animal Health declared a quarterly dividend on Monday, February 6th. Investors of record on Wednesday, March 1st will be given a dividend of $0.12 per share on Wednesday, March 22nd. This represents a $0.48 dividend on an annualized basis and a dividend yield of 3.30%. The ex-dividend date is Tuesday, February 28th. Read our dividend analysis for PAHC. What ETFs hold Phibro Animal Health's stock? ETFs with the largest weight of Phibro Animal Health (NASDAQ:PAHC) stock in their portfolio include Invesco S&P SmallCap High Dividend Low Volatility ETF (XSHD), Invesco Nasdaq Future Gen 200 ETF (QQQS), First Trust Dow Jones Select Microcap Index Fund (FDM), Hartford Multifactor Small Cap ETF (ROSC), ETC 6 Meridian Low Beta Equity Strategy ETF (SIXL), Invesco S&P SmallCap 600 Pure Value ETF (RZV), Royce Quant Small-Cap Quality Value ETF (SQLV) and Invesco S&P SmallCap Health Care ETF (PSCH). Is Phibro Animal Health a good dividend stock? Phibro Animal Health (NASDAQ:PAHC) pays an annual dividend of $0.48 per share and currently has a dividend yield of 3.20%. The dividend payout ratio is 53.33%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, PAHC will have a dividend payout ratio of 35.04% next year. This indicates that the company will be able to sustain or increase its dividend. Read our dividend analysis for PAHC. What guidance has Phibro Animal Health issued on next quarter's earnings? Phibro Animal Health issued an update on its FY 2023 earnings guidance on Wednesday, February, 8th. The company provided earnings per share guidance of $1.21-$1.31 for the period, compared to the consensus EPS estimate of $1.20. The company issued revenue guidance of $960.00M-$1.00 billion, compared to the consensus revenue estimate of $982.11 million. What is Jack Bendheim's approval rating as Phibro Animal Health's CEO? 4 employees have rated Phibro Animal Health Chief Executive Officer Jack Bendheim on Glassdoor.com. Jack Bendheim has an approval rating of 100% among the company's employees. This puts Jack Bendheim in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Phibro Animal Health own? Based on aggregate information from My MarketBeat watchlists, some companies that other Phibro Animal Health investors own include Zynga (ZNGA), Trevena (TRVN), Endo International (ENDP), Sonoma Pharmaceuticals (SNOA), Zynerba Pharmaceuticals (ZYNE), Intercept Pharmaceuticals (ICPT), VIVUS (VVUS), Zoetis (ZTS), Banco Bradesco (BBD) and Booking (BKNG). What is Phibro Animal Health's stock symbol? Phibro Animal Health trades on the NASDAQ under the ticker symbol "PAHC." Who are Phibro Animal Health's major shareholders? Phibro Animal Health's stock is owned by a variety of retail and institutional investors. Top institutional investors include Pzena Investment Management LLC (4.86%), Heartland Advisors Inc. (1.76%), Renaissance Technologies LLC (1.31%), Dimensional Fund Advisors LP (1.28%), Smith Graham & Co. Investment Advisors LP (1.18%) and Morgan Stanley (1.15%). Insiders that own company stock include E Thomas Corcoran and Larry Lee Miller. View institutional ownership trends. How do I buy shares of Phibro Animal Health? Shares of PAHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Phibro Animal Health's stock price today? One share of PAHC stock can currently be purchased for approximately $14.53. How much money does Phibro Animal Health make? Phibro Animal Health (NASDAQ:PAHC) has a market capitalization of $588.52 million and generates $972.05 million in revenue each year. The company earns $49.17 million in net income (profit) each year or $0.90 on an earnings per share basis. How many employees does Phibro Animal Health have? The company employs 1,860 workers across the globe. How can I contact Phibro Animal Health? Phibro Animal Health's mailing address is GLENPOINTE CENTRE EAST 3RD FLOOR 300 FRANK W. BURR BLVD. SUITE 21, TEANECK NJ, 07666. The official website for the company is www.pahc.com. The company can be reached via phone at (201) 329-7300, via email at investor.relations@pahc.com, or via fax at 201-329-7399. This page (NASDAQ:PAHC) was last updated on 3/24/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.